VentriPoint Diagnostics Ltd.
VPTDF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $16 | $47 | $40 | $48 |
| - Cash | $0 | $1 | $5 | $9 |
| + Debt | $2 | $0 | $0 | $0 |
| Enterprise Value | $17 | $46 | $36 | $39 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 93.5% | -27.8% | – | – |
| Gross Profit | $0 | $0 | $0 | -$0 |
| % Margin | 100% | 86.3% | 84.8% | – |
| EBITDA | -$5 | -$5 | -$5 | -$4 |
| % Margin | -5,002% | -9,651.4% | -7,032.3% | – |
| Net Income | -$5 | -$5 | -$5 | -$4 |
| % Margin | -5,169.1% | -9,905.7% | -7,148.3% | – |
| EPS Diluted | -0.031 | -0.031 | -0.031 | -0.029 |
| % Growth | 0% | 0.3% | -9.5% | – |
| Operating Cash Flow | -$3 | -$4 | -$4 | -$3 |
| Capital Expenditures | $0 | $0 | $0 | -$0 |
| Free Cash Flow | -$3 | -$4 | -$4 | -$3 |